-+ 0.00%
-+ 0.00%
-+ 0.00%

Icure Pharmaceutical Suspends Patch Manufacturing for 15 Days Starting Nov. 18

PUBT·11/06/2026 09:32:12
Icure Pharmaceutical Suspends Patch Manufacturing for 15 Days Starting Nov. 18
  • Icure Pharmaceutical will suspend patch manufacturing for 15 days, from Nov. 18 through Dec. 2, 2026, under an administrative order.
  • The affected business accounts for KRW 13.89 billion in revenue, or 16.77% of total sales.
  • The suspension concerns recordkeeping and procedural violations, not product quality. Sales activities remain unrestricted.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Icure Pharmaceutical Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106000463), on November 06, 2026, and is solely responsible for the information contained therein.